Dr Jonathan Coleman
Memorial Sloan Kettering Cancer Center, USA

Dr Mark Emberton
University College London, UK

Dr Jurgen Futterer
Radboud University Medical Center, The Netherlands

Dr Rajan Gupta
Duke University Medical Center, USA

Dr Masoom Haider
University of Toronto, Canada

Dr Daniel Margolis
UCLA, USA

Dr Cynthia Menard
University of Montreal, Canada

Dr Peter Pinto
National Cancer Institute, NIH, USA

Dr Robert Reiter
UCLA, USA

Dr Samir Taneja
New York University, USA

Dr Theodorus van der Kwast
University of Toronto, Canada

Faculty Disclosure

It is the policy of University of Toronto, Faculty of Medicine, Continuing Professional Development to ensure balance, independence, objectivity, and scientific rigor in all its individually accredited or jointly accredited educational programs. Speakers and/or planning committee members, participating in University of Toronto accredited programs, are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships within the last FIVE (5) years with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of facts. It remains for the audience to determine whether the speaker's outside interests may reflect a possible bias in either the exposition or the conclusions presented.